PATENT CLAIM ANALYSIS

Application Number: 16196140
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["514", "255050"]

Abstract:
The present invention is directed to compounds of Formulas (I, IIa and IIb): The invention also relates to pharmaceutical compositions comprising compounds of Formulas (I, IIa and IIb). Methods of making and using the compounds of Formulas (I, IIa and IIb) are also within the scope of the invention.

Claim (Index 35):
A compound, or pharmaceutically acceptable salt thereof, selected from the group consisting of:

Metadata:
- Claim Count in Document: 35.0
- Percentile: 98.0
- Lexical Diversity: 2.03333
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15258320', '14212669', '14775432', '14714714', '14775417']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8167460908743291
- 35 USC 102 Novelty (BERT): 0.54839359564304
- Combined Prediction Score: 0.7899108413512003
- Mean Citation Score: 409.920608
- Max Citation Score: 434.52582
- Similarity Product: 235.65564843758227

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test